Cargando…
Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in...
Autores principales: | Montanari, Floriane, Zdrazil, Barbara, Digles, Daniela, Ecker, Gerhard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743411/ https://www.ncbi.nlm.nih.gov/pubmed/26855674 http://dx.doi.org/10.1186/s13321-016-0121-y |
Ejemplares similares
-
Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors
por: Montanari, Floriane, et al.
Publicado: (2016) -
Empowering pharmacoinformatics by linked life science data
por: Goldmann, Daria, et al.
Publicado: (2016) -
Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P‐Glycoprotein (P‐gp) and Breast Cancer Resistance Protein (BCRP)
por: Schwarz, Theresa, et al.
Publicado: (2016) -
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators
por: Dei, Silvia, et al.
Publicado: (2019) -
Automated design of ligands to polypharmacological profiles
por: Besnard, Jérémy, et al.
Publicado: (2012)